RxDoctor Payments Data

Myranda Partin

Optometrist · Oklahoma City, OKNPI 1205313178

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 228 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 24.7% of the total. Reporting peaked in 2021 at $1,525 and has fallen 53.9% since, to $704 in 2025. Among optometrist clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,635in general payments, 2019–2025

Across 228 payments — averaging $29.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Alcon$836
  • Glaukos Corporation$605
  • Novartis$420
  • Eyevance Pharmaceuticals LLC$367
  • Sun Pharmaceutical Industries Inc.$354
  • plus $2K from 19 others

What the payments were for

  • Food & beverage$6,635100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,635 in reported general payments places this provider in the 95th percentile of 714 optometrist providers in Oklahoma.

See all optometrist providers in Oklahoma

Medicare billing

Part B allowed, 2024
$10,074
Medicare patients
63
Services billed
126

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Latanoprost25$552
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat11$247

Paid to pharmacies, not to this prescriber.

Other optometrist in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →